Efficacy and Safety of Tofacitinib and Adalimumab in Rheumatoid Arthritis by Body Mass Index-Normalized Methotrexate Dose: A Post Hoc Analysis
- DOI
- 10.1007/s40744-025-00823-0
- Published
- 2026-01-22
- Container
- Rheumatology and Therapy
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s40744-025-00823-0,
title = {Efficacy and Safety of Tofacitinib and Adalimumab in Rheumatoid Arthritis by Body Mass Index-Normalized Methotrexate Dose: A Post Hoc Analysis},
author = {Tsutomu Takeuchi and Yoshiya Tanaka and Hisashi Yamanaka and Kunihiro Yamaoka and Naonobu Sugiyama and Noriko Iikuni and Shigeyuki Toyoizumi and Kenneth Kwok and Wen-Chan Tsai and Eduardo Mysler and Robert J. Moots and Josef S. Smolen and Roy Fleischmann},
year = {2026},
journal = {Rheumatology and Therapy},
doi = {10.1007/s40744-025-00823-0},
url = {https://doi.org/10.1007/s40744-025-00823-0}
}RIS
TY - JOUR TI - Efficacy and Safety of Tofacitinib and Adalimumab in Rheumatoid Arthritis by Body Mass Index-Normalized Methotrexate Dose: A Post Hoc Analysis AU - Tsutomu Takeuchi AU - Yoshiya Tanaka AU - Hisashi Yamanaka AU - Kunihiro Yamaoka AU - Naonobu Sugiyama AU - Noriko Iikuni AU - Shigeyuki Toyoizumi AU - Kenneth Kwok AU - Wen-Chan Tsai AU - Eduardo Mysler AU - Robert J. Moots AU - Josef S. Smolen AU - Roy Fleischmann PY - 2026 JO - Rheumatology and Therapy DO - 10.1007/s40744-025-00823-0 UR - https://doi.org/10.1007/s40744-025-00823-0 ER -
APA
Takeuchi, T., Tanaka, Y., Yamanaka, H., Yamaoka, K., Sugiyama, N., Iikuni, N., Toyoizumi, S., Kwok, K., Tsai, W., Mysler, E., Moots, R. J., Smolen, J. S., & Fleischmann, R. (2026). Efficacy and Safety of Tofacitinib and Adalimumab in Rheumatoid Arthritis by Body Mass Index-Normalized Methotrexate Dose: A Post Hoc Analysis. Rheumatology and Therapy. https://doi.org/10.1007/s40744-025-00823-0
Source records
- crossref · retrieved 2026-09-25T15:39:07.810Z